A new randomized trial in The Lancet suggests semaglutide may meaningfully reduce heavy drinking and cravings in adults …
A new randomized trial in The Lancet suggests semaglutide may meaningfully reduce heavy drinking and cravings in adults …
GLP-1 therapies are often framed around weight loss and glucose control, but emerging research suggests they may also …
GLP-1 medications reduce appetite, but they cannot outrun alcohol, poor sleep, and inflammatory meals. Here is how I …
Metformin has long been a cornerstone of PCOS care, but many women need more. Here’s what a 2025 …
The latest ACSM Position Stand confirms what I see in clinic every week: muscle is one of the …
Peptides are one of the fastest-growing tools in longevity medicine, but the real safety question isn’t what you’re …
Midlife weight gain isn’t a willpower problem. It’s a physiology shift, and the newest incretin therapies are pointing …
Peptides are everywhere in the longevity conversation right now – and a lot of it is hype. Here’s …
